Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23059159 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
Condition: Schizophrenia
Interventions: Drug: BL - 1020;   Drug: Placebo;   Drug: Risperidone

Indicates status has not been verified in more than two years